Filing Details

Accession Number:
0001209191-21-049672
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-04 16:56:49
Reporting Period:
2021-08-02
Accepted Time:
2021-08-04 16:56:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1726445 Seer Inc. SEER Laboratory Analytical Instruments (3826) 821153150
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1834217 R. David Horn C/O Seer, Inc.
3800 Bridge Parkway, Suite 102
Redwood City CA 94065
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-08-02 10,000 $2.70 240,966 No 4 M Direct
Class A Common Stock Disposition 2021-08-02 7,903 $31.11 233,063 No 4 S Direct
Class A Common Stock Disposition 2021-08-02 2,097 $31.52 230,966 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (right to buy) Disposition 2021-08-02 10,000 $0.00 10,000 $2.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
596,547 2030-04-01 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2021.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.41 to $31.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.41 to $31.86, inclusive.
  4. The shares underlying the option are subject to an early exercise provision and are immediately exercisable. One-fourth of the shares underlying the option vested on April 1, 2021 and 1/48th of the shares vest monthly thereafter.